Bags of shred­ded docs: In­di­an drug­mak­er Lupin hand­ed a Form 483 by FDA in­spec­tors

The gener­ics man­u­fac­tur­er Lupin has been giv­en an­oth­er Form 483 from the FDA this year.

US reg­u­la­tors in­spect­ed Lupin’s phar­ma­ceu­ti­cal man­u­fac­tur­ing site in the town …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.